Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Emcor
EME
$35.7B
| $6.24M | ﹤0.01% |
72,468
-9,410
| -11% | -$801K |
|
1652
Shopify
SHOP
$200B
| $6.23M | ﹤0.01% |
199,930
+130,280
| +187% | +$4.46M |
|
|
BLD
1653
DELISTED
TopBuild
BLD
| $6.22M | ﹤0.01% |
64,538
-9,624
| -13% | -$850K |
|
1654
PUT
BP
BP
$110B
| $6.21M | ﹤0.01% |
163,600
-27,062
| -14% | -$1.03M |
|
1655
HEICO Corp Class A
HEI.A
$37B
| $6.21M | ﹤0.01% |
63,831
+38,385
| +151% | +$4.07M |
|
1656
PUT
Ionis Pharmaceuticals
IONS
$9.46B
| $6.21M | ﹤0.01% |
103,600
+79,100
| +323% | +$5.16M |
|
|
BBBY
1657
DELISTED
Bed Bath & Beyond Inc
BBBY
| $6.21M | ﹤0.01% |
583,099
+398,057
| +215% | +$3.84M |
|
1658
CALL
ArcelorMittal
MT
$55.7B
| $6.2M | ﹤0.01% |
435,400
+131,000
| +43% | +$2.01M |
|
|
WCC
1659
WESCO International
WCC
$17.9B
| $6.2M | ﹤0.01% |
129,754
+49,822
| +62% | +$2.35M |
|
|
CGC
1660
Canopy Growth
CGC
$402M
| $6.2M | ﹤0.01% |
27,021
+8,382
| +45% | +$2.56M |
|
|
SKX
1661
DELISTED
Skechers
SKX
| $6.19M | ﹤0.01% |
165,798
+44,276
| +36% | +$1.52M |
|
1662
Sensata Technologies
ST
$6.66B
| $6.19M | ﹤0.01% |
123,662
+22,632
| +22% | +$1.07M |
|
1663
Park Hotels & Resorts
PK
$2.92B
| $6.17M | ﹤0.01% |
247,239
+246,994
| +100,814% | +$6.27M |
|
|
GHDX
1664
DELISTED
Genomic Health, Inc.
GHDX
| $6.16M | ﹤0.01% |
90,862
+56,207
| +162% | +$3.86M |
|
1665
PUT
Teva Pharmaceuticals
TEVA
$42.1B
| $6.16M | ﹤0.01% |
894,800
+140,200
| +19% | +$1.07M |
|
1666
Agnico Eagle Mines
AEM
$91.4B
| $6.14M | ﹤0.01% |
114,624
+53,166
| +87% | +$3.01M |
|
1667
CALL
PVH
PVH
$4.02B
| $6.13M | ﹤0.01% |
69,500
+43,200
| +164% | +$3.61M |
|
1668
CALL
iQIYI
IQ
$1.31B
| $6.13M | ﹤0.01% |
379,800
-16,500
| -4% | -$303K |
|
1669
Guardant Health
GH
$22.4B
| $6.11M | ﹤0.01% |
95,655
+77,245
| +420% | +$6.81M |
|
1670
Telus
TU
$15.1B
| $6.08M | ﹤0.01% |
341,190
+114,792
| +51% | +$2.09M |
|
|
VRAY
1671
DELISTED
ViewRay, Inc.
VRAY
| $6.08M | ﹤0.01% |
2,095,498
+1,997,240
| +2,033% | +$11.8M |
|
1672
InterDigital
IDCC
$8.99B
| $6.08M | ﹤0.01% |
115,777
-495,378
| -81% | -$28M |
|
1673
Brixmor Property Group
BRX
$9.15B
| $6.06M | ﹤0.01% |
298,600
-181,544
| -38% | -$3.41M |
|
1674
PUT
Thermo Fisher Scientific
TMO
$222B
| $6.06M | ﹤0.01% |
20,800
+16,400
| +373% | +$4.7M |
|
|
GWPH
1675
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $6.05M | ﹤0.01% |
52,600
-23,000
| -30% | -$3.49M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.